Results 101 to 110 of about 1,368 (177)

Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Aho VTE, Klee M, Landoulsi Z, Heintz-Buschart A, Pavelka L, Leist AK, Krüger R, May P, Wilmes P, NCER-PD Consortium.   +9 more
europepmc   +1 more source

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia. [PDF]

Mov Disord
Sosero YL, Bandres-Ciga S, Ferwerda B, Tocino MTP, Belloso DR, Gómez-Garre P, Gómez-Garre P, Faouzi J, Taba P, Pavelka L, Marques TM, Gomes CPC, Kolodkin A, May P, Milanowski LM, Wszolek ZK, Uitti RJ, Heutink P, van Hilten JJ, Simon DK, Eberly S, Alvarez I, Krohn L, Yu E, Freeman K, Rudakou U, Ruskey JA, Asayesh F, Menéndez-Gonzàlez M, Pastor P, Ross OA, Krüger R, NCER‐PD Consortium, Corvol JC, Koks S, Mir P, De Bie RMA, Iwaki H, Gan-Or Z, International Parkinson's Disease Genomic Consortium.   +39 more
europepmc   +1 more source

Multifactorial assessment of Parkinson's disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort - extension of the LONG-PD study. [PDF]

Front Aging Neurosci, 2023
Chase BA, Krueger R, Pavelka L, Chung SJ, Aasly J, Dardiotis E, Premkumar AP, Schoneburg B, Kartha N, Aunaetitrakul N, Frigerio R, Maraganore D, Markopoulou K.   +12 more
europepmc   +1 more source

Water-Soluble Bimodal Magnetic-Fluorescent Radical Dendrimers as Potential MRI-FI Imaging Probes. [PDF]

ACS Appl Mater Interfaces
Wu Y, Lloveras V, Morgado A, Perez-Inestrosa E, Babaliari E, Psilodimitrakopoulos S, Vida Y, Vidal-Gancedo J.   +7 more
europepmc   +1 more source

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study. [PDF]

Drugs Real World Outcomes, 2020
Szerman N, Basurte-Villamor I, Vega P, Martinez-Raga J, Parro-Torres C, Cambra Almerge J, Grau-López L, De Matteis M, Arias F.   +8 more
europepmc   +1 more source

Comprehensive blood metabolomics profiling of Parkinson's disease reveals coordinated alterations in xanthine metabolism. [PDF]

NPJ Parkinsons Dis
de Lope EG, Loo RTJ, Rauschenberger A, Ali M, Pavelka L, Marques TM, Gomes CPC, Krüger R, Glaab E, NCER-PD Consortium.   +9 more
europepmc   +1 more source

Disease Surveillance during the Reintroduction of the Iberian Lynx (Lynx pardinus) in Southwestern Spain. [PDF]

Animals (Basel), 2021
Nájera F, Grande-Gómez R, Peña J, Vázquez A, Palacios MJ, Rueda C, Corona-Bravo AI, Zorrilla I, Revuelta L, Gil-Molino M, Jiménez J.   +10 more
europepmc   +1 more source

Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson's disease. [PDF]

NPJ Digit Med
Brzenczek C, Klopfenstein Q, Hähnel T, Sapienza S, Klucken J, Fröhlich H, Glaab E, NCER-PD Consortium.   +7 more
europepmc   +1 more source

"Cool" and "Hot" executive functions in deaf children: the executive brain battery (EBB). [PDF]

J Deaf Stud Deaf Educ
Fernández-García L, Maurno NG, Phillips-Silver J, González MTD.   +3 more
europepmc   +1 more source

Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs. [PDF]

PLoS Pathog, 2022
Gestuveo RJ, Parry R, Dickson LB, Lequime S, Sreenu VB, Arnold MJ, Khromykh AA, Schnettler E, Lambrechts L, Varjak M, Kohl A.   +10 more
europepmc   +1 more source